Viroblock SA
PLAN-LES-OUATES, Switzerland, October 28, 2011 -
Viroblock S.A., a company with a highly innovative, broadly applicable anti-viral air filtration technology, initially focused on development and commercialization of anti-viral face-masks, today announced the successful closure of a 3.3 million CHF Series C financing round.
GENEVA, February 3 - Viroblock SA, a start-up dedicated to developing and
commercializing a new generation of anti-viral products, today announced that
Dr.
PLAN-LES-OUATES, Switzerland - Viroblock SA announces that its antiviral products boosts the efficacy of facemasks by at least 99.0%, i.e.
